Choong Ang Vaccine Laboratory Co. Ltd (072020) — Cash Flow-to-Debt Ratio
Choong Ang Vaccine Laboratory Co. Ltd (072020) has a Cash Flow-to-Debt Ratio of 0.13x as of March 2026, meaning its operating cash flow of ₩2.30 Billion could theoretically repay 0% of its total liabilities (₩17.61 Billion) in one year. Explore Choong Ang Vaccine Laboratory Co. Ltd (072020) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Choong Ang Vaccine Laboratory Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Choong Ang Vaccine Laboratory Co. Ltd across 12 annual periods. Also explore how large is Choong Ang Vaccine Laboratory Co. Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for Choong Ang Vaccine Laboratory Co. Ltd. For market capitalisation and broader financial context, see 072020 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | ₩7.87 Billion | ₩17.45 Billion | ▼ -34.7% |
| 2024 | 0.69x | ₩13.40 Billion | ₩19.41 Billion | ▲ +7.5% |
| 2023 | 0.64x | ₩12.71 Billion | ₩19.79 Billion | ▲ +77.2% |
| 2022 | 0.36x | ₩7.09 Billion | ₩19.55 Billion | ▼ -37.2% |
| 2021 | 0.58x | ₩11.53 Billion | ₩19.98 Billion | ▲ +20.9% |
| 2020 | 0.48x | ₩8.32 Billion | ₩17.43 Billion | ▼ -41.4% |
| 2019 | 0.81x | ₩8.30 Billion | ₩10.20 Billion | ▲ +67.3% |
| 2018 | 0.49x | ₩5.71 Billion | ₩11.74 Billion | ▲ +9.0% |
| 2017 | 0.45x | ₩7.56 Billion | ₩16.95 Billion | ▼ -23.7% |
| 2016 | 0.59x | ₩7.71 Billion | ₩13.18 Billion | ▼ -57.4% |
| 2015 | 1.37x | ₩9.93 Billion | ₩7.22 Billion | ▲ +77.5% |
| 2014 | 0.77x | ₩6.67 Billion | ₩8.61 Billion | — |